Sirott v. East Bay Medical Oncology CA1/2

CourtCalifornia Court of Appeal
DecidedJanuary 28, 2022
DocketA161353
StatusUnpublished

This text of Sirott v. East Bay Medical Oncology CA1/2 (Sirott v. East Bay Medical Oncology CA1/2) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sirott v. East Bay Medical Oncology CA1/2, (Cal. Ct. App. 2022).

Opinion

Filed 1/28/22 Sirott v. East Bay Medical Oncology CA1/2 NOT TO BE PUBLISHED IN OFFICIAL REPORTS California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

FIRST APPELLATE DISTRICT

DIVISION TWO

MATTHEW SIROTT et al., Plaintiffs and Appellants, A161353; A161555 v. EAST BAY MEDICAL (Alameda County ONCOLOGY et al., Super. Ct. No. RG20064527) Defendants and Respondents.

Appellants were claimants and counter-respondents in an arbitration held before three experienced arbitrators. Following five days of hearing, the arbitrators issued a final award, which award incorporated a comprehensive 46-page decision finding for appellants on two of their claims, but awarded less than they sought; the decision also found against appellants on a counter-claim. Appellants filed a petition to correct the award that was denied by the superior court in an 11-page order. Appellants assert essentially the same three arguments rejected below, arguing that the award must be corrected in three specific ways. We conclude that none of the arguments has merit, and we affirm.

1 BACKGROUND The Parties, the Participants, and the General Setting This appeal is by Matthew Sirott, M.D. and Robert Robles, M.D., derivatively on behalf of California Radiation Treatment Center, LLC (CRTC), (when referred to collectively, appellants). CRTC is a limited liability company that was founded in 2008 for the purpose of acquiring and operating radiation therapy equipment for lease to medical groups practicing medical and radiation oncology. It has an operating agreement that expires in 2028. CRTC has three members: Sirott, who owns 25 percent; Robles, who owns 25 percent;1 and East Bay Medical Oncology-Hematology Medical Associates, Inc. (usually Epic), which owns 50 percent. Sirott and Robles are also associated with a medical group known as Diablo Valley Oncology and Hematology Medical Group, Inc. (DVO). The managers of CRTC are Sirott and Bimal Patel, M.D., the latter of whom is President and CEO of Epic. CRTC leases a portion of the building at 400 Taylor Boulevard, Pleasant Hill. The building is owned by 400 Taylor Holdings, LLC, which in turn is owned by Sirott (25 percent), Robles (25 percent), and EBO Properties North, LLC (50 percent). The managers of 400 Taylor Holdings, LLC are Patel and Sirott. Patel is also the manager of EBO Properties North, LLC. CRTC owns radiation therapy equipment, specifically two Elekta Synergy linear accelerators (Linacs) that are installed in concrete vaults in the building at 400 Taylor Boulevard. The Epic physicians and the DVO physicians both use the CRTC facilities in treating their respective patients, subleasing the facilities for such use. Epic and DVO doctors bill and collect

1For consistency with most of the proceedings below, and briefing here, we refer to the participants, many of whom are physicians, by their last name.

2 their fees from their patients/insurers; and from what they collect, a portion is paid to CRTC for the sublease use of the personnel services, space, and equipment owned by CRTC. In 2014, trouble began to brew after DVO hired a physician, Dr. Karamlou, who had previously been with Epic. According to Patel, this caused a “lack of trust” between DVO and Epic. Sometime in 2015, Patel, in conjunction with other Epic doctors (and third parties), began exploring the potential for acquiring a CyberKnife machine, a fact he disclosed to Sirott in about December 2016. At a subsequent CRTC meeting, Sirott told Patel his plan to acquire a CyberKnife was a business opportunity of CRTC that should be pursued by it. Patel declined because he wanted to dissolve CRTC and cease investing in it. In January 2017, Patel and others formed the CyberKnife Center, LLC (the Center) to operate a CyberKnife radiation treatment machine. The Center leases a building with the CyberKnife equipment at 3003 Oak Street, Walnut Creek, within five miles of the CRTC space, which building and equipment are owned by ECCC Properties, LLC (ECCC). The Center is owned by Epic (75 percent) and an entity known as Select Health Care (Select) (25 percent). The Center became operative in June 2017, for the purpose of operating a cancer radiation treatment facility, leading to the arbitration here. The Arbitration In August 2017, appellants, derivatively on behalf of CRTC, filed a demand for arbitration pursuant to section 14.7 of the CRTC Operating Agreement, a demand that made two claims on behalf of CRTC and one personal claim. The first derivative claim alleged that in establishing the

3 Center, Epic and Patel breached section 5.12 of the Operating Agreement by competing and usurping a business opportunity of CTRC. The second derivative claim alleged that the complained-of conduct breached Patel’s fiduciary duty as a manager of CTRC. And the personal claim sought the attorney fees and arbitration costs involved in bringing the derivative claims. Epic and Patel (when referred to collectively respondents) responded with three counterclaims. The first counter-claim was for breach of contract against Sirott, claiming that in disregard of its regular practice, CRTC did not make its usual and customary distributions for a nine-month period (September 2016 to May 2017) because Sirott, as a manager of CRTC, refused to approve them. The second counter-claim sought an accounting of those delayed distributions. And the third alleged that the delay in distributions breached Sirott’s fiduciary duty, and sought actual and punitive damages and Sirott’s removal as manager of CRTC. The CRTC operating agreement provides that the arbitration shall be conducted in accordance with the commercial arbitration rules of the American Arbitration Association (AAA), and three arbitrators were designated to serve: The Honorable Nickolas Dibiaso (Ret.), The Honorable Brian Van Camp (Ret.), and Professor Jack Garvey. The arbitrators heard evidence for five days, following which the parties filed post-hearing briefs, and then supplemental briefs on the issue of constructive trust. Following all that, on November 19, 2019, the arbitrators issued their unanimous “final interim decision.” It was 46 pages in length, a thoughtful, comprehensive decision that analyzed in detail the issues before them, which issues will be discussed in detail below to the extent they bear on the arguments raised by appellants. Suffice to say here that the decision began with six pages of background; a description of the “issues presented”;

4 seven pages of “discussion and analysis; and a lengthy discussion of “remedies.” And included within that discussion was an exhaustive 15-page explanation why the testimony of appellants’ expert witness on damages was insufficient to support appellants’ claimed damages, which concluded that appellants “have not proved the amount of CRTC’s damages with respect to either their cause of action for breach of contract or their cause of action for breach of fiduciary duty.” Reaching that conclusion, the arbitrators determined that as triers of fact under AAA Commercial Rule R-34(b), they were entitled to reject the expert’s opinion, as it did not rest on a reasonable basis in evidentiary fact or express convincing analytical reasoning. And as a result, the arbitrators awarded nominal compensatory damages of $1.00 for Patel’s and Epic’s breach of contract and breach of fiduciary duty. The arbitrators also denied appellants’ alternative request for the imposition of a constructive trust, finding they failed to establish the necessary elements for that remedy.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Mother Cobb's Chicken Turnovers, Inc. v. Fox
73 P.2d 1185 (California Supreme Court, 1937)
Brewer v. Second Baptist Church
197 P.2d 713 (California Supreme Court, 1948)
Moncharsh v. Heily & Blase
832 P.2d 899 (California Supreme Court, 1992)
Sweet v. Johnson
337 P.2d 499 (California Court of Appeal, 1959)
Steinberg v. Amplica, Inc.
729 P.2d 683 (California Supreme Court, 1986)
Moshonov v. Walsh
996 P.2d 699 (California Supreme Court, 2000)
Moore v. First Bank of San Luis Obispo
996 P.2d 706 (California Supreme Court, 2000)
Weiss v. Marcus
51 Cal. App. 3d 590 (California Court of Appeal, 1975)
Heckert v. MacDonald
208 Cal. App. 3d 832 (California Court of Appeal, 1989)
Kraus v. Willow Park Public Golf Course
73 Cal. App. 3d 354 (California Court of Appeal, 1977)
Dakota Gardens Apartment Investors" B" v. Pudwill
75 Cal. App. 3d 346 (California Court of Appeal, 1977)
Hicks v. Clayton
67 Cal. App. 3d 251 (California Court of Appeal, 1977)
Cramer v. Biddison
257 Cal. App. 2d 720 (California Court of Appeal, 1968)
Fletcher v. A. J. Industries, Inc.
266 Cal. App. 2d 313 (California Court of Appeal, 1968)
City of Richmond v. Service Employees International Union
189 Cal. App. 4th 663 (California Court of Appeal, 2010)
Jordan v. Department of Motor Vehicles
123 Cal. Rptr. 2d 122 (California Court of Appeal, 2002)
Cziraki v. Thunder Cats, Inc.
3 Cal. Rptr. 3d 419 (California Court of Appeal, 2003)
COTCHETT, PITRE & McCARTHY v. Universal Paragon Corp.
187 Cal. App. 4th 1405 (California Court of Appeal, 2010)
Baize v. Eastridge Companies, LLC
47 Cal. Rptr. 3d 763 (California Court of Appeal, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
Sirott v. East Bay Medical Oncology CA1/2, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sirott-v-east-bay-medical-oncology-ca12-calctapp-2022.